FR2338925B1 - - Google Patents

Info

Publication number
FR2338925B1
FR2338925B1 FR7702122A FR7702122A FR2338925B1 FR 2338925 B1 FR2338925 B1 FR 2338925B1 FR 7702122 A FR7702122 A FR 7702122A FR 7702122 A FR7702122 A FR 7702122A FR 2338925 B1 FR2338925 B1 FR 2338925B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7702122A
Other languages
French (fr)
Other versions
FR2338925A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2900/76A external-priority patent/GB1577114A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2338925A1 publication Critical patent/FR2338925A1/fr
Application granted granted Critical
Publication of FR2338925B1 publication Critical patent/FR2338925B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7702122A 1976-01-26 1977-01-26 Nouveaux peptides et medicament contenant ces substances Granted FR2338925A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2900/76A GB1577114A (en) 1976-01-26 1976-01-26 Biologically active peptides
GB848176 1976-03-03
GB4882176 1976-11-23

Publications (2)

Publication Number Publication Date
FR2338925A1 FR2338925A1 (fr) 1977-08-19
FR2338925B1 true FR2338925B1 (xx) 1980-08-08

Family

ID=27254145

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7702122A Granted FR2338925A1 (fr) 1976-01-26 1977-01-26 Nouveaux peptides et medicament contenant ces substances

Country Status (11)

Country Link
JP (1) JPS5291839A (xx)
CH (1) CH644352A5 (xx)
DE (1) DE2703109A1 (xx)
DK (1) DK33177A (xx)
ES (1) ES455365A1 (xx)
FI (1) FI70228C (xx)
FR (1) FR2338925A1 (xx)
HU (1) HU184704B (xx)
IL (1) IL51332A (xx)
NL (1) NL7700785A (xx)
SE (1) SE7708404L (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003000A (en) * 1975-05-27 1977-01-11 Sperry Rand Corporation Sinusoidal oscillator with electronically variable frequency
US4261888A (en) * 1976-04-12 1981-04-14 Sandoz Ltd. Organic compounds
FR2359817A1 (fr) * 1976-07-27 1978-02-24 Reckitt & Colmann Prod Ltd Nouveaux peptides, leur procede de preparation et composition therapeutique les contenant
JPS5321140A (en) * 1976-08-09 1978-02-27 Searle & Co Production of 11substituted enkephalin derivatives
HU178001B (en) * 1976-09-16 1982-02-28 Gyogyszekutato Intezet Process for preparing new pentapeptides with morphine-like activity and derivatives thereof
DE2819277A1 (de) * 1977-05-16 1978-11-23 Sandoz Ag Neue polypeptidderivate, ihre herstellung und verwendung
GB2000784B (en) * 1977-07-05 1982-01-20 American Home Prod Analgesic polypetide
EP0000559B1 (en) * 1977-07-22 1983-10-05 The Wellcome Foundation Limited Pentapeptide-n-alkylamides and their acid addition salts, methods for preparation of these compounds and pharmaceutical formulations containing them
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
HU182051B (en) * 1978-05-02 1983-12-28 Takeda Chemical Industries Ltd Process for preparing tetrapeptide-hydrazyde derivatives
US4278596A (en) * 1978-08-08 1981-07-14 American Home Products Corporation Analgesic pentapeptides
CA1175810A (en) * 1979-03-30 1984-10-09 Frank A. Momany Synthetic peptides having pituitary growth hormone releasing activity
US4247543A (en) * 1979-04-09 1981-01-27 Sandoz Ltd. Organic compounds
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
DE3163199D1 (en) * 1980-07-17 1984-05-24 Sandoz Ag Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
FR2488253A1 (fr) * 1980-08-08 1982-02-12 Roques Bernard Nouveaux peptides et leur application en therapeutique
WO1983002272A1 (en) * 1981-12-28 1983-07-07 Beckman Instruments Inc Synthetic peptides having pituitary growth hormone releasing activity
US4491541A (en) * 1982-11-10 1985-01-01 Farmitalia Carlo Erba Peptides
JPH0680079B2 (ja) * 1984-11-09 1994-10-12 エーザイ株式会社 ポリペプチド
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
DK0644772T3 (da) * 1992-11-12 2003-06-30 Sod Conseils Rech Applic Opioid-peptider
CA2757036C (en) * 2009-04-13 2015-09-15 Elc Management Llc Methionine sulfoxide peptide, compositions and methods of use
TW201920234A (zh) 2017-09-11 2019-06-01 美商領導醫療有限公司 類鴉片促效劑肽及其用途

Also Published As

Publication number Publication date
ES455365A1 (es) 1978-05-16
CH644352A5 (en) 1984-07-31
FI70228C (fi) 1986-09-15
IL51332A (en) 1980-09-16
DE2703109A1 (de) 1977-08-04
DK33177A (da) 1977-07-27
IL51332A0 (en) 1977-03-31
FI70228B (fi) 1986-02-28
FR2338925A1 (fr) 1977-08-19
JPS5291839A (en) 1977-08-02
NL7700785A (nl) 1977-07-28
SE7708404L (sv) 1977-07-27
FI770254A (xx) 1977-07-27
HU184704B (en) 1984-10-29

Similar Documents

Publication Publication Date Title
FR2338925B1 (xx)
DE2705663C3 (xx)
DE2604246C2 (xx)
DE2720421C2 (xx)
JPS5523568B2 (xx)
DE2706795C2 (xx)
FR2370780B1 (xx)
DE2660696A1 (xx)
JPS5549557B2 (xx)
JPS5520000B2 (xx)
JPS5342807U (xx)
JPS5351011U (xx)
JPS5726252Y2 (xx)
JPS53106U (xx)
JPS5533910B2 (xx)
JPS5338786U (xx)
JPS5543524Y2 (xx)
JPS536893U (xx)
JPS52145925U (xx)
JPS5348076U (xx)
JPS52101134U (xx)
JPS52101254U (xx)
JPS5361757U (xx)
JPS52118058U (xx)
JPS537200U (xx)

Legal Events

Date Code Title Description
ST Notification of lapse